These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
360 related items for PubMed ID: 28941142
1. Coordination-Accelerated "Iron Extraction" Enables Fast Biodegradation of Mesoporous Silica-Based Hollow Nanoparticles. Wang L, Huo M, Chen Y, Shi J. Adv Healthc Mater; 2017 Nov; 6(22):. PubMed ID: 28941142 [Abstract] [Full Text] [Related]
2. "Manganese Extraction" Strategy Enables Tumor-Sensitive Biodegradability and Theranostics of Nanoparticles. Yu L, Chen Y, Wu M, Cai X, Yao H, Zhang L, Chen H, Shi J. J Am Chem Soc; 2016 Aug 10; 138(31):9881-94. PubMed ID: 27441571 [Abstract] [Full Text] [Related]
9. Polydopamine coated hollow mesoporous silica nanoparticles as pH-sensitive nanocarriers for overcoming multidrug resistance. Shao M, Chang C, Liu Z, Chen K, Zhou Y, Zheng G, Huang Z, Xu H, Xu P, Lu B. Colloids Surf B Biointerfaces; 2019 Nov 01; 183():110427. PubMed ID: 31408782 [Abstract] [Full Text] [Related]
10. Fabrication of high specificity hollow mesoporous silica nanoparticles assisted by Eudragit for targeted drug delivery. She X, Chen L, Velleman L, Li C, Zhu H, He C, Wang T, Shigdar S, Duan W, Kong L. J Colloid Interface Sci; 2015 May 01; 445():151-160. PubMed ID: 25617610 [Abstract] [Full Text] [Related]
11. A pH/ROS-responsive, tumor-targeted drug delivery system based on carboxymethyl chitin gated hollow mesoporous silica nanoparticles for anti-tumor chemotherapy. Ding X, Yu W, Wan Y, Yang M, Hua C, Peng N, Liu Y. Carbohydr Polym; 2020 Oct 01; 245():116493. PubMed ID: 32718608 [Abstract] [Full Text] [Related]
12. Hollow mesoporous silica nanoparticles facilitated drug delivery via cascade pH stimuli in tumor microenvironment for tumor therapy. Liu J, Luo Z, Zhang J, Luo T, Zhou J, Zhao X, Cai K. Biomaterials; 2016 Mar 01; 83():51-65. PubMed ID: 26773665 [Abstract] [Full Text] [Related]
15. A facile route for rapid synthesis of hollow mesoporous silica nanoparticles as pH-responsive delivery carrier. Xu H, Zhang H, Wang D, Wu L, Liu X, Jiao Z. J Colloid Interface Sci; 2015 Aug 01; 451():101-7. PubMed ID: 25890118 [Abstract] [Full Text] [Related]
16. Bovine serum albumin-based and dual-responsive targeted hollow mesoporous silica nanoparticles for breast cancer therapy. Zhang Y, Ye Z, He R, Li Y, Xiong B, Yi M, Chen Y, Liu J, Lu B. Colloids Surf B Biointerfaces; 2023 Apr 01; 224():113201. PubMed ID: 36822117 [Abstract] [Full Text] [Related]
17. Iron-engineered mesoporous silica nanocatalyst with biodegradable and catalytic framework for tumor-specific therapy. Wang L, Huo M, Chen Y, Shi J. Biomaterials; 2018 May 01; 163():1-13. PubMed ID: 29452944 [Abstract] [Full Text] [Related]
18. Molecularly organic/inorganic hybrid hollow mesoporous organosilica nanocapsules with tumor-specific biodegradability and enhanced chemotherapeutic functionality. Huang P, Chen Y, Lin H, Yu L, Zhang L, Wang L, Zhu Y, Shi J. Biomaterials; 2017 May 01; 125():23-37. PubMed ID: 28226244 [Abstract] [Full Text] [Related]
20. Controlled intracellular release of doxorubicin in multidrug-resistant cancer cells by tuning the shell-pore sizes of mesoporous silica nanoparticles. Gao Y, Chen Y, Ji X, He X, Yin Q, Zhang Z, Shi J, Li Y. ACS Nano; 2011 Dec 27; 5(12):9788-98. PubMed ID: 22070571 [Abstract] [Full Text] [Related] Page: [Next] [New Search]